Rapid Nexus Nanotech Receives FDA Clearance for Next-Gen Chronic Wound Dressing
Summary: Rapid Nexus Nanotech Wound Solutions, Inc. has been granted FDA clearance for its nanotechnology-based advanced wound dressing specifically indicated for diabetic foot ulcers and venous leg ulcers. The platform uses proprietary silver-free antimicrobial nanoparticles that reportedly maintain moist healing environment while reducing bioburden for up to 7 days.
Key Highlights:
- First non-silver nanoparticle dressing with specific DFU/VLU labeling
- Part of recent wave of FDA digital health/wound tech approvals
- Company claims faster granulation and 35–40% reduction in healing time in pilot data
Article mentioning the clearance →
Keywords: Rapid Nexus, FDA clearance, nanotechnology dressing, diabetic foot ulcers, silver-free antimicrobial